which plasma biomarkers hold the most promise in alzheimer’s disease?
Published 2 years ago • 138 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:36
using plasma biomarkers in the diagnosis of alzheimer’s disease
-
4:07
plasma versus neuroimaging biomarkers for alzheimer’s disease clinical trials
-
2:11
upcoming plasma biomarkers for alzheimer’s disease: aβ, p-tau and gfap
-
1:23
plasma biomarkers for alzheimer's disease as pre-screening tools
-
2:57
the potential of plasma biomarkers in dementia
-
1:45
the accuracy of plasma biomarkers for alzheimer’s disease outside of a controlled setting
-
1:45
the use of alzheimer’s disease plasma biomarkers in the clinic: further research needed
-
2:25
plasma biomarkers for population-based alzheimer’s disease screening
-
2:09
alzheimer’s disease plasma biomarkers across the spectrum: which perform best?
-
4:05
plasma biomarkers and genetics in the diagnosis and prediction of alzheimer’s disease
-
3:10
promise of exosomal proteins as biomarkers in alzheimer’s disease
-
1:36
bringing plasma biomarkers into clinical practice: what does the future hold?
-
2:20
the ability of plasma p-tau231 to detect preclinical alzheimer’s disease
-
1:28
impact of blood-based biomarkers on alzheimer’s disease treatments
-
1:08:22
diagnosing alzheimer’s disease in the biomarker era: promises and pitfalls | professor ron petersen
-
3:18
biomarkers for alzheimer’s disease: past, present and future
-
6:32
blood biomarkers in alzheimer’s disease: appropriate use recommendations
-
1:40
blood-based biomarkers for alzheimer’s disease screening
-
1:02
blood biomarkers for the diagnosis of alzheimer's disease